Effects of ezetimibe/simvastatin compared to simvastatin monotherapy in reducing C-reactive protein and low density lipoprotein-cholesterol

被引：0
|
作者：
Ballantyne, CM
Ridker, P
Pearson, T
Veltri, E
Mitchel, YB
Sisk, CMM
Shah, AK
Maccubbin, DL
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2006年 / 47卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：316A / 316A
页数：1
相关论文
共 50 条
  • [1] Effects of ezetimibe/simvastatin compared to simvastatin monotherapy in reducing C-reactive protein and low density lipoprotein-cholesterol
    Ballantyne, C. M.
    Ridker, P.
    Pearson, T.
    Veltri, E.
    Mitchel, Y. B.
    Sisk, C. M. Mc Crary
    Shah, A.
    Maccubbin, D. L.
    EUROPEAN HEART JOURNAL, 2006, 27 : 945 - 945
  • [2] Comparison of effects, of Ezetimibe/Simvastatin versus Simvastatin versus Atorvastatin in reducing C-reactive protein and low-density lipoprotein cholesterol levels
    Pearson, Thomas
    Ballantyne, Christie
    Sisk, Christine
    Shah, Arvind
    Veltri, Enrico
    Maccubbin, Darbie
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (12): : 1706 - 1713
  • [3] Pleiotropic Effects With Equivalent Low-density Lipoprotein Cholesterol Reduction: Comparative Study Between Simvastatin and Simvastatin/Ezetimibe Coadministration
    Araujo, Daniel B.
    Bertolami, Marcelo C.
    Ferreira, Waldinai P.
    Abdalla, Dulcineia S. P.
    Faludi, Andre A.
    Nakamura, Yara
    Bricharello, Liliana P.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2010, 55 (01) : 1 - 5
  • [4] Evaluation of the ezetimibe/simvastatin tablet compared with atorvastatin or rosuvastatin on C-reactive protein in patients with hypercholesterolemia
    Catapano, A. L.
    Ballantyne, C. M.
    Abate, N.
    Davidson, M. H.
    Brady, W. E.
    Gazzara, R. A.
    Tershakovec, A.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 555 - 555
  • [5] Simvastatin lowers C-reactive protein within 14 days - An effect independent of low-density lipoprotein cholesterol reduction
    Plenge, JK
    Hernandez, TL
    Weil, KM
    Poirier, P
    Grunwald, GK
    Marcovina, SM
    Eckel, RH
    CIRCULATION, 2002, 106 (12) : 1447 - 1452
  • [6] Effects of ezetimibe coadministered with simvastatin on C-reactive protein in a large cohort of hypercholesterolemic patients
    Sager, PT
    Capece, R
    Lipka, L
    Strony, J
    Yang, B
    Suresh, R
    Mitchel, Y
    Veltri, E
    ATHEROSCLEROSIS, 2005, 179 (02) : 361 - 367
  • [7] Pooled Analyses of Effects on C-Reactive Protein and Low Density Lipoprotein Cholesterol in Placebo-Controlled Trials of Ezetimibe Monotherapy or Ezetimibe Added to Baseline Statin Therapy
    Pearson, Thomas A.
    Ballantyne, Christie M.
    Veltri, Enrico
    Shah, Arvind
    Bird, Steven
    Lin, Jianxin
    Rosenberg, Elizabeth
    Tershakovec, Andrew M.
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 103 (03): : 369 - 374
  • [8] Effects of simvastatin on C-reactive protein (ESP) trial: A dose-response study of simvastatin and C-reactive protein
    Jones, HU
    Muhlestein, JB
    Maycock, CAA
    Sohrevardi, M
    Jensen, M
    Pearson, RR
    Horne, BD
    Anderson, JL
    CIRCULATION, 2002, 106 (19) : 320 - 320
  • [9] Ezetimibe added to rosuvastatin for severely hypercholesterolemic patients: Effects on low-density lipoprotein cholesterol and C-reactive protein
    Stein, EA
    Harris, S
    Schleman, M
    Sage, PT
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 392A - 392A
  • [10] Effects of simvastatin and ezetimibe on interleukin-6 and high-sensitivity C-reactive protein
    Berthold, Heiner K.
    Berneis, Kaspar
    Mantzoros, Christos S.
    Krone, Wilhelm
    Gouni-Berthold, Ioanna
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2013, 47 (01) : 20 - 27
12345